U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658560) titled 'A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes' on June 11.
Brief Summary: To evaluate the efficacy of BGM0504 tablets compared with placebo in reducing body weight in overweight or obese participants without diabetes after 20 weeks of treatment.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Overweight or Obese Participants Without Diabetes
Intervention:
DRUG: BGM0504 tablets
Administered p.o once daily
DRUG: BGM0504 tablets
Administered p.o once daily
DRUG: BGM0504 tablets
Administered p.o once daily
DRUG: BGM0504 tablets
Administered p....